Biotech · Public company · San Carlos, CA, US
Attovia Therapeutics, Inc.
Ticker ATTO · SEC CIK 0002058707
Track this companyFree. Adds Attovia Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- ATTO-1310Phase 1 · Normal VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ATTO-3712Phase 1 · Normal VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic DermatitisPHASE1 · COMPLETED · started Oct 22, 2025ClinicalTrials.gov NCT07205081 · fetched Nov 12, 2026
- Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic PruritusPHASE1 · COMPLETED · started Jan 14, 2025ClinicalTrials.gov NCT06787586 · fetched Nov 12, 2026
SEC filings9
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Sep 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 424B4 · 424B4SEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Jul 29, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Jul 14, 2026 · fetched Nov 12, 2026